ODP350 Safety and Efficacy of Tesomet over 48 Weeks of Treatment: Results From a 24-Week Phase 2, Randomized, Double-Blind Study With 24 Week Open-Label Extension in Adults With Hy...

por Klose, Marianne, Huynh, Kim, Krogsgaard, Kim, Drejer, Jørgen, Pharm, Dr, Byberg, Sarah, Madsbad, Sten, Magkos, Faidon, Researcher, Senior, Aharaz, Abdellatif, Edsberg, Berit, Tfelt, Jacob, Astrup, Arne, Feldt-Rasmussen, Ulla
Publicado 2022